Michael Ayers, MD, is an Associate Professor of Medicine in Cardiology at UVA, where he directs the Center for Excellence in Hypertrophic Cardiomyopathy and previously held multiple educational and administrative leadership roles. He now serves as Senior Director of Clinical Development at Edgewise Therapeutics, a biotechnology company focused on sarcomeric modulation. Dr. Ayers specializes in inherited cardiomyopathies, with advanced training in multi-modality cardiovascular imaging, sports cardiology, and inherited lipid disorders. His research centers on cardiac mechanics, leveraging advanced imaging to elucidate pharmacologic mechanisms and the potential for disease modification with novel therapeutics. He has led multiple international and investigator-initiated clinical trials as a principal investigator. He serves on committees within the ACC, AHA, and NHLBI. His honors include the Proctor Harvey Award from the American College of Cardiology as the field’s most outstanding educator, the UVA Dean’s Award for Excellence in Teaching, and selection as a national finalist for the American Heart Association’s Laennec Young Clinician Award. Dr. Ayers completed his internal medicine residency, cardiology fellowship, and advanced imaging training at the University of Pennsylvania, and completed undergraduate at Duke University.
Associate Professor
Medical School
2014
Residency
Fellowship
2020